![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung c... Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527. Show more
Met primary endpoint demonstrating clinically meaningful and statistically significant complete response rate across both dose groupsFirst large, randomized, placebo-controlled study to...
- EMBARQ-CSU1 and EMBARQ-CSU 2 will enroll more than 1800 patients suffering from CSU -- Studies include both biologic naΓ―ve and experienced patients - HAMPTON, N.J., July 16, 2024 (GLOBE...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.25 | -3.35840945728 | 37.22 | 46.86 | 35.81 | 812970 | 41.34295887 | CS |
4 | -0.63 | -1.72131147541 | 36.6 | 46.86 | 35 | 610206 | 39.19759456 | CS |
12 | -6.64 | -15.5831964328 | 42.61 | 46.86 | 32.25 | 630444 | 37.43205735 | CS |
26 | -0.34 | -0.936381162214 | 36.31 | 53.18 | 32.25 | 785888 | 40.83449674 | CS |
52 | 1.42 | 4.10998552822 | 34.55 | 53.18 | 22.11 | 716585 | 36.25602753 | CS |
156 | -8.73 | -19.5302013423 | 44.7 | 57.2 | 19.85 | 610919 | 35.89260943 | CS |
260 | 33.73 | 1505.80357143 | 2.24 | 57.2 | 1.5 | 700250 | 25.50486206 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions